# Effect of C-peptide on Hypoglycemic Counterregulation

> **NCT06470295** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Cincinnati** · enrollment: 38 (estimated)

## Conditions studied

- Hypoglycemia
- Type 1 Diabetes

## Interventions

- **OTHER:** Saline
- **BIOLOGICAL:** C-peptide

## Key facts

- **NCT ID:** NCT06470295
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06470295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06470295, "Effect of C-peptide on Hypoglycemic Counterregulation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06470295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*